The direct and indirect effects of lurasidone monotherapy on functional improvement among patients with bipolar depression: results from a randomized placebo-controlled trial

被引：0
|
作者：
Krithika Rajagopalan
Elizabeth Dansie Bacci
Kathleen W. Wyrwich
Andrei Pikalov
Antony Loebel
机构：
[1] Sunovion Pharmaceuticals Inc.,
[2] Evidera,undefined
[3] Sunovion Pharmaceuticals Inc.,undefined
[4] Evidera,undefined
来源：
International Journal of Bipolar Disorders | / 4卷
关键词：
Sheehan disability scale; Patient functioning; Bipolar disorder; Depression;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Preventing depression after stroke: Results from a randomized placebo-controlled trial
    Almeida, Osvaldo P.
    Waterreus, Anna
    Hankey, Graerne J.
    JOURNAL OF CLINICAL PSYCHIATRY, 2006, 67 (07) : 1104 - 1109
  • [22] Lurasidone for bipolar I depression with anxiety: Post-hoc analysis of a randomized, placebo-controlled study
    Hagi, Katsuhiko
    Shima, Hirokazu
    Inoue, Takeshi
    BIPOLAR DISORDERS, 2021, 23 : 70 - 71
  • [23] Optimizing Treatment with Lurasidone in Patients with Schizophrenia: Results: of a Randomized, Double-blind, Placebo-controlled Trial (OPTIMIZE Trial)
    Loebel, Antony
    Silva, Robert
    Goldman, Robert
    Watabe, Kei
    Cucchiaro, Josephine
    Kane, John
    NEUROPSYCHOPHARMACOLOGY, 2014, 39 : S476 - S477
  • [24] Nebivolol Monotherapy for Patients With Systolic Stage II Hypertension: Results of a Randomized, Placebo-Controlled Trial
    Lewin, Andrew
    Punzi, Henry
    Luo, Xiaohui
    Stapff, Manfred
    CLINICAL THERAPEUTICS, 2013, 35 (02) : 142 - 152
  • [25] Symptomatic remission in patients with bipolar mania: Results from a double-blind, placebo-controlled trial of risperidone monotherapy
    Gopal, S
    Steffens, DC
    Kramer, ML
    Olsen, MK
    JOURNAL OF CLINICAL PSYCHIATRY, 2005, 66 (08) : 1016 - 1020
  • [26] EFFICACY OF LOW DOSE LURASIDONE IN PATIENTS WITH SCHIZOPHRENIA: RESULTS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    Kane, John M.
    Silva, Robert
    Goldman, Robert
    Watabe, Kei
    Cucchiaro, Josephine
    Loebel, Antony
    SCHIZOPHRENIA BULLETIN, 2015, 41 : S317 - S317
  • [27] Relationship Between Symptomatic and Functional Improvement During Cariprazine Treatment in Patients With Bipolar I Depression: Post Hoc Analysis of a Randomized, Placebo-Controlled Trial
    McIntyre, Roger
    Tohen, Mauricio
    Mattingly, Greg
    Vieta, Eduard
    Yu, Jun
    Nguyen, Huy-Binh
    NEUROPSYCHOPHARMACOLOGY, 2024, 49 : 136 - 137
  • [28] A Randomized, Double-Blind, Placebo-Controlled Trial of Pregnenolone for Bipolar Depression
    E Sherwood Brown
    John Park
    Christine E Marx
    Linda S Hynan
    Claire Gardner
    Domingo Davila
    Alyson Nakamura
    Prabha Sunderajan
    Alexander Lo
    Traci Holmes
    Neuropsychopharmacology, 2014, 39 : 2867 - 2873
  • [29] Zonisamide for Bipolar Depression: A Randomized, Double Blind, Placebo-Controlled, Adjunctive Trial
    Dauphinais, Deborah
    Knable, Michael
    Rosenthal, Joshua
    Polanski, Mark
    Rosenthal, Norman
    PSYCHOPHARMACOLOGY BULLETIN, 2011, 44 (02) : 73 - 84
  • [30] Adjunctive lumateperone (ITI-007) in the treatment of bipolar depression: Results from a randomized placebo-controlled clinical trial
    Suppes, Trisha
    Durgam, Suresh
    Kozauer, Susan G.
    Chen, Richard
    Lakkis, Hassan D.
    Davis, Robert E.
    Satlin, Andrew
    Vanover, Kimberly E.
    Mates, Sharon
    McIntyre, Roger S.
    Tohen, Mauricio
    BIPOLAR DISORDERS, 2023, 25 (06) : 478 - 488
12345